Exact Mass: 637.2863127999999
Exact Mass Matches: 637.2863127999999
Found 108 metabolites which its exact mass value is equals to given mass value 637.2863127999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
milbemycin alpha9
18-(p-Iodophenyl)octadecyl phosphocholine
C29H53INO4P (637.2756777999999)
Acetylmaymyrsine
7-(3-Pyridinecarbonyl),3-butanoyl,5-propanoyl,15-Ac-Myrsinol
C35H43NO10 (637.2886818000001)
1beta-cis-cinnamoyl-4alpha,5alpha-dihydroxy-7beta,11-diacetoxy-8beta-nicotinoyldihydroagarofuran|triptersinine D
7-(3-Pyridinecarbonyl),5-butanoyl,3-propanoyl,15-Ac-Myrsinol
C35H43NO10 (637.2886818000001)
Tris(dihydrocaffeoyl)spermidine
His Arg Tyr Tyr
His Tyr Arg Tyr
His Tyr Tyr Arg
Asn Arg Trp Tyr
Asn Arg Tyr Trp
Asn Trp Arg Tyr
Asn Trp Tyr Arg
Asn Tyr Arg Trp
Asn Tyr Trp Arg
Arg His Tyr Tyr
Arg Asn Trp Tyr
Arg Asn Tyr Trp
Arg Trp Asn Tyr
Arg Trp Tyr Asn
Arg Tyr His Tyr
Arg Tyr Asn Trp
Arg Tyr Trp Asn
Arg Tyr Tyr His
Trp Asn Arg Tyr
Trp Asn Tyr Arg
Trp Arg Asn Tyr
Trp Arg Tyr Asn
Trp Tyr Asn Arg
Trp Tyr Arg Asn
Tyr His Arg Tyr
Tyr His Tyr Arg
Tyr Asn Arg Trp
Tyr Asn Trp Arg
Tyr Arg His Tyr
Tyr Arg Asn Trp
Tyr Arg Trp Asn
Tyr Arg Tyr His
Tyr Trp Asn Arg
Tyr Trp Arg Asn
Tyr Tyr His Arg
Tyr Tyr Arg His
2-methyl-4-[[4-[[4-[(3-tolyl)amino]phenyl][4-[(3-tolylimino]-2,5-cyclohexadien-1-ylidene]methyl]phenyl]amino]benzenesulphonic acid
(6aS,7R,13S,14R,16R)-16-(((tert-butyldimethylsilyl)oxy)methyl)-5-hydroxy-9-methoxy-8-(methoxymethoxy)-4,10,17-trimethyl-6,6a,7,13,14,16-hexahydro-12H-7,13-epiminobenzo[4,5]azocino[1,2-b][1,3]dioxolo[4,5-h]isoquinoline-14-carbonitrile
Apramycin sulfate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Apramycin sulfate is an aminoglycoside antibiotic produced by Streptomyces murica and used in veterinary medicine.
(Pro18,Asp21)-Amyloid β-Protein (17-21) trifluoroacetate salt
C33H43N5O8 (637.3111478000001)
β-Sheet Breaker Peptide iAβ5 is a potent degrader of cerebral amyloid-beta (Abeta). Abeta deposition is associatied with the Alzheimer disease (AD), due to its related toxicity linked to its beta-sheet conformation and/or aggregation. β-Sheet Breaker Peptide iAβ5 reproducibly induces in vivo disassembly of fibrillar amyloid deposits. Thus, β-Sheet Breaker Peptide iAβ5 prevents and/or reverses neuronal shrinkage caused by Abeta, and reduces the extent of interleukin-1beta positive microglia-like cells that surround the Abeta deposits. β-Sheet Breaker Peptide iAβ5 reduces the size and/or number of cerebral amyloid plaques in AD. β-Sheet Breaker Peptide iAβ5 labeled by hydrophobic benzyl alcohol (HBA) tag, can be used for quantitative assay by showing vivid blue color under acidic conditions[1][2][3].
Luminate
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2144 - Endothelial-Specific Integrin/Survival Signaling Inhibitor
Ethanaminium, 2-((hydroxy((18-(4-(iodo-131I)phenyl)octadecyl)oxy)phosphinyl)oxy)-N,N,N-trimethyl-, inner salt
C29H53INO4P (637.2756777999999)
C1446 - Radiopharmaceutical Compound > C129819 - Antineoplastic Radiopharmaceutical Agent C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate C274 - Antineoplastic Agent
18-(p-Iodophenyl)octadecyl phosphocholine
C29H53INO4P (637.2756777999999)
N-caffeoyl O-methyltyramine-4,5-O-beta-D-diglucoside
(7E,9R,10R,11R,12R,13R,14R,15R,16S,17R,18Z,20E)-4,10,12,14,16-pentahydroxy-3,7,9,11,13,15,17,21,25-nonamethyl-23-azatricyclo[22.3.1.05,27]octacosa-1(27),2,4,7,18,20,24-heptaene-6,22,26,28-tetrone
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins
[(10E,14E,16E)-21,24-dihydroxy-5,6,11,13-tetramethyl-2-oxospiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2-oxane]-22-yl]methyl 1H-pyrrole-2-carboxylate
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
(2S)-2-amino-3-[[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C32H48NO10P (637.3015677999999)
1-(9Z-octadecenoyl)-2-glutaryl-sn-glycero-3-phosphoserine
NY2267
C38H43N3O6 (637.3151697999999)
NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM. NY2267 inhibits Myc- and Jun-induced transcriptional activation[1].
(3s,4s,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
(1s,14s)-9,20,21,25-tetramethoxy-15,15,30-trimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2³,⁶.1⁸,¹².1¹⁴,¹⁸.0²⁷,³¹.0²²,³³]hexatriaconta-3,5,8(34),9,11,18(33),19,21,24,26,31,35-dodecaen-15-ium
[4,5,8-tris(acetyloxy)-7-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl pyridine-2-carboxylate
7-(acetyloxy)-2-(butanoyloxy)-5,9-dimethyl-8-oxo-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate
C35H43NO10 (637.2886818000001)
(3s,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
(1s,2r,3s,4s,5s,7r,9s,10r,11s,14r)-7-(acetyloxy)-2-(butanoyloxy)-5,9-dimethyl-8-oxo-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate
C35H43NO10 (637.2886818000001)
(1s,2r,4s,5r,6r,7s,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-4-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
(1s,2r,3s,4s,5s,7r,9s,10r,11s,14r)-7-(acetyloxy)-4-(butanoyloxy)-5,9-dimethyl-8-oxo-11-(prop-1-en-2-yl)-2-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate
C35H43NO10 (637.2886818000001)
(1s,14r)-9,20,21,25-tetramethoxy-15,15,30-trimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2³,⁶.1⁸,¹².1¹⁴,¹⁸.0²⁷,³¹.0²²,³³]hexatriaconta-3,5,8(34),9,11,18(33),19,21,24,26,31,35-dodecaen-15-ium
5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-4-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
[(1s,2r,4s,5r,6s,7s,8s,9r)-4,5,8-tris(acetyloxy)-7-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl pyridine-2-carboxylate
(1s,2s,4r,5r,6r,7r,9r,12s)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-4-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
7-(acetyloxy)-4-(butanoyloxy)-5,9-dimethyl-8-oxo-11-(prop-1-en-2-yl)-2-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate
C35H43NO10 (637.2886818000001)